Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127224131 | 12722413 | 1 | I | 20160729 | 20160825 | 20160907 | 20160907 | EXP | FR-AFSSAPS-RN20161325 | FR-FRI-1000087242 | FOREST | 47.32 | YR | F | Y | 0.00000 | 20160907 | OT | DK | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127224131 | 12722413 | 1 | PS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | Y | 21323 | ||||||||||
| 127224131 | 12722413 | 2 | SS | ADVAGRAF | TACROLIMUS | 1 | Oral | 2.5 MG | Y | 0 | 2.5 | MG | QD | ||||||
| 127224131 | 12722413 | 3 | SS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | 40 MG | Y | 0 | 40 | MG | GASTRO-RESISTANT COATED TABLET | QD | |||||
| 127224131 | 12722413 | 4 | SS | XANAX | ALPRAZOLAM | 1 | Oral | Y | 0 | ||||||||||
| 127224131 | 12722413 | 5 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG | Y | 0 | 10 | MG | COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127224131 | 12722413 | 1 | Depression |
| 127224131 | 12722413 | 2 | Prophylaxis against transplant rejection |
| 127224131 | 12722413 | 3 | Abdominal pain upper |
| 127224131 | 12722413 | 4 | Anxiety |
| 127224131 | 12722413 | 5 | Cardiovascular event prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127224131 | 12722413 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127224131 | 12722413 | Alanine aminotransferase increased | |
| 127224131 | 12722413 | Aspartate aminotransferase increased | |
| 127224131 | 12722413 | Blood alkaline phosphatase increased | |
| 127224131 | 12722413 | Gamma-glutamyltransferase increased | |
| 127224131 | 12722413 | Hepatitis cholestatic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127224131 | 12722413 | 1 | 201607 | 20160729 | 0 | |
| 127224131 | 12722413 | 2 | 201607 | 20160729 | 0 | |
| 127224131 | 12722413 | 3 | 201607 | 20160729 | 0 | |
| 127224131 | 12722413 | 4 | 201607 | 20160729 | 0 | |
| 127224131 | 12722413 | 5 | 20160729 | 0 |